Cargando…
Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutation
Lung cancer is still the main cause of cancer-related deaths worldwide, with most patients present with advanced disease and poor long-term prognosis. The aim of lung cancer treatment is to slow down the progression of the disease, to relieve the patients from the lung cancer symptoms and whenever p...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934098/ https://www.ncbi.nlm.nih.gov/pubmed/27433059 http://dx.doi.org/10.4103/0976-9668.184695 |